Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A generous gift from The Sir John Ritblat Family Foundation has enabled the creation of a new Professorship in Mindfulness and Psychological Science. The post, which is to be held by the Director of the Oxford Mindfulness Centre, promises to transform our understanding of the link between mind and body, and lead the world into a new era of human health.

None
A MINDFULNESS-BASED COGNITIVE THERAPY TRAINING SESSION LED BY WILLEM KUYKEN AND MARK WILLIAMS (SHANGHAI, 2018)

Sometimes described as 'the art of conscious living', mindfulness is a natural capacity for moment-by-moment awareness – a practice that enables us to change the way we think and feel about our experiences by developing attentiveness to the present. In recent years, mindfulness has become a recognised form of treatment for both physical and emotional health in mainstream medicine.

Oxford now sits at the forefront of mindfulness research and teaching internationally. Through the Oxford Mindfulness Centre (OMC) – established in 2008 within the Department of Psychiatry – researchers combine ancient wisdom with rigorous contemporary science to better understand the practice's potential for improving health and wellbeing.

The centre's current research agenda has been developed in close collaboration with policy-makers, and the OMC is now undertaking major studies into the promise of mindfulness in education, the workplace and criminal justice systems. The establishment of a permanent post in mindfulness – the first of its kind globally – will enable Oxford to build a permanent research and training centre, and continue to be a leader in this field.

Read more (Oxford Thinking website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.